CausalSentinel

Protein Dossier — MSR1 (Macrophage scavenger receptor types I and II)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Myocardial infarction -0.129 0.0368 4.76e-04 Wald ratio 1 trans NA
Coronary heart disease -0.111 0.0334 8.64e-04 Wald ratio 1 trans NA
Amyotrophic lateral sclerosis -0.197 0.0604 0.00113 Wald ratio 1 trans NA
Eczema 0.178 0.0591 0.00266 Wald ratio 1 trans NA
Years of schooling -0.0394 0.0131 0.0027 Wald ratio 1 trans NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.141 0.048 0.0033 Wald ratio 1 trans NA
Chronic kidney disease 0.145 0.0526 0.00596 Wald ratio 1 trans NA
Forced vital capacity (FVC) -0.0177 0.0065 0.00649 Wald ratio 1 trans NA
LDL cholesterol -0.0496 0.0184 0.00701 Wald ratio 1 trans NA
Sodium in urine 0.0197 0.0078 0.0115 Wald ratio 1 trans NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) -0.165 0.0666 0.0133 Wald ratio 1 trans NA
Heel bone mineral density (BMD) T-score automated 0.0251 0.0103 0.0143 Wald ratio 1 trans NA
…and 100 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3684_78_3 Macrophage scavenger receptor Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

147 association rows across 90 traits (112 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating MSR1 levels 7e-323 rs76393968 9 GCST90859674 no MR -> candidate analysis
MSR1 protein levels 2e-246 rs10103856 6 GCST90469950 no MR -> candidate analysis
C1QTNF5 protein levels 5e-205 rs73665255 8 GCST90468489 no MR -> candidate analysis
LGALS3BP protein levels 5e-187 rs73665255 7 GCST90469760 no MR -> candidate analysis
Galectin-3-binding protein levels 9e-172 rs41341748 4 GCST90247672 no MR -> candidate analysis
Macrophage scavenger receptor types I and II levels 4e-119 rs41341748 6 GCST90248385 no MR -> candidate analysis
FOLR2/MSR1 protein level ratio 1e-76 rs17583220 1 GCST90314866 no MR -> candidate analysis
Cerebrospinal fluid protein MSR1 levels 9e-76 rs41341748 1 GCST90944440 no MR -> candidate analysis
Cerebrospinal fluid protein C1QTNF5 levels 3e-44 rs41341748 1 GCST90944136 no MR -> candidate analysis
ITGBL1 protein levels 3e-32 rs41341748 2 GCST90469648 no MR -> candidate analysis
PTX3 protein levels 3e-32 rs41341748 2 GCST90470392 no MR -> candidate analysis
MMP3 protein levels 6e-31 rs41341748 1 GCST90469920 no MR -> candidate analysis
…and 78 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 435 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Barrett esophagus 0.63 established (curated) no MR -> candidate analysis
ovarian cancer 0.641 established (curated) MR: beta=-0.192, p=0.248 (trans)
esophageal adenocarcinoma 0.547 established (curated) no MR -> candidate analysis
alcohol drinking 0.548 common-variant locus no MR -> candidate analysis
urolithiasis 0.548 common-variant locus no MR -> candidate analysis
cannabis dependence 0.542 common-variant locus no MR -> candidate analysis
keloid 0.523 common-variant locus no MR -> candidate analysis
cervical carcinoma 0.492 common-variant locus no MR -> candidate analysis
fungal infectious disease 0.495 common-variant locus no MR -> candidate analysis
sialadenitis 0.492 common-variant locus no MR -> candidate analysis
carcinoma of esophagus 0.486 established (curated) no MR -> candidate analysis
bipolar disorder 0.478 common-variant locus MR: beta=0.0814, p=0.348 (trans)
muscle cramp 0.424 common-variant locus no MR -> candidate analysis
coronary artery disorder 0.404 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.396 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Macrophage scavenger receptor types I and II)
gnomAD constraint pLI=1.9e-20, LOEUF=1.41 — LoF-tolerant
GWAS Catalog 117 unique SNPs / 185 rows
ClinVar 239 records; 4 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance